Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer

Clinical trial NCT06992648 · RECRUITING

Trial details

NCT number: NCT06992648
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic Colorectal Cancer Recurrent

Start date: 2025-04-01
Primary completion: 2027-12-31
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.